ClassID:

20328

A61K31/4164 - page 6 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole 1,3-Diazoles

Recent Application in this class:
#1501
20100305158
2010-12-02

METHOD FOR THE TREATMENT OR PREVENTION OF LOWER URINARY TRACT SYMPTOMS

#1502
20100305105
2010-12-02

Phenylsulfoxyoxazole compound inhibitors of urea transporters

#1503
20100303799
2010-12-02

Treatment of conditions related to shock

#1504
20100298396
2010-11-25

Manufacture, compositions and uses of coagulation factor VIIa modulator

#1505
20100286219
2010-11-11

1, 3-Dihydroimidazoles for Treating Cardiovascular Disorders

#1506
20100285134
2010-11-11

PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND/OR THE PREVENTION OF OSTEOARTICULAR DISEASES

#1507
20100273846
2010-10-28

Method for treating proliferative disorders associated with mutations in c-Met

#1508
20100272781
2010-10-28

Sugar Free Chewable Tablets

#1509
20100267637
2010-10-21

TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH A KINASE INHIBITOR

#1510
20100256165
2010-10-07

LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER

#1511
20100256081
2010-10-07

Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions

#1512
20100255016
2010-10-07

Absorbable crystalline polyether-ester-urethane-based bioactive luminal liner compositions

#1513
20100249185
2010-09-30

Method for inhibiting topoisomerase II

#1514
20100249175
2010-09-30

Dicationic compounds which selectively recognize G-quadruplex DNA

#1515
20100240726
2010-09-23

Compositions for treating amyloid associated diseases

#1516
20100239632
2010-09-23

DRUG DEPOTS FOR TREATMENT OF PAIN AND INFLAMMATION IN SINUS AND NASAL CAVITIES OR CARDIAC TISSUE

#1517
20100233109
2010-09-16

Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α-adrenoceptor agonists

#1518
20100227867
2010-09-09

Compounds, formulations, and methods for treating or preventing inflammatory skin disorders

#1519
20100222388
2010-09-02

Enhanced migraine treatments based on ghrelin mimetics

#1520
20100216840
2010-08-26

BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS

#1521
20100216778
2010-08-26

PAIN REMEDY CONTAINING ROCK INHIBITOR

#1522
20100215756
2010-08-26

Pharmaceutical preparations containing highly volatile silicones

#1523
20100209507
2010-08-19

Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions

#1524
20100204286
2010-08-12

METHOD FOR REDUCING GASTROINTESTINAL ADVERSE EFFECTS OF CYTOTOXIC AGENTS

#1525
20100204173
2010-08-12

METHODS OF TREATING HEPATIC ENCEPHALOPATHY

#1526
20100197694
2010-08-05

Compositions and methods for treatment of diseases and conditions with increased vascular permeability

#1527
20100179235
2010-07-15

Compositions comprising bile acid sequestrants for treating esophageal disorders

#1528
20100168200
2010-07-01

Antifungal pharmaceutical composition

#1529
20100168198
2010-07-01

Mitochondria-targeted antioxidant prodrugs and methods of use

#1530
20100160444
2010-06-24

Method to inhibit ischemia and reperfusion injury

#1531
20100160401
2010-06-24

4-PHENYLIMIDAZOLE-2-THIONE TYROSINASE INHIBITORS AND TREATMENT OR PREVENTION OF PIGMENTARY DISORDERS THEREWITH

#1532
20100159032
2010-06-24

COMBINATIONS USEFUL FOR THE TREATMENT OF NEURONAL DISORDERS

#1533
20100158796
2010-06-24

Amides of hyaluronic acid and the derivatives thereof and a process for their preparation

#1534
20100152272
2010-06-17

Functionalized drugs and polymers derived therefrom

#1535
20100151013
2010-06-17

Gastric acid secretion inhibiting composition

#1536
20100144748
2010-06-10

Methods involving aldose reductase inhibitors

#1537
20100144733
2010-06-10

Compounds, compositions and methods comprising heteroaromatic derivatives

#1538
20100144647
2010-06-10

Dual acting prodrugs

#1539
20100144610
2010-06-10

PHARMACEUTICAL FORMULATIONS

#1540
20100137389
2010-06-03

Topical formulation

#1541
20100130574
2010-05-27

Neurodegenerative diseases and methods of modeling

#1542
20100130502
2010-05-27

Compounds, Formulations, and Methods for Treating or Preventing Inflammatory Skin Disorders

#1543
20100120876
2010-05-13

Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide

#1544
20100113477
2010-05-06

Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof

#1545
20100113377
2010-05-06

Method of treatment using alpha-1-adrenergic agonist compounds

#1546
20100112064
2010-05-06

Transdermal therapeutic system comprising ion pair microreservoirs

#1547
20100105750
2010-04-29

STABLE METRONIDAZOLE GEL FORMULATIONS

#1548
20100104642
2010-04-29

Hydrophilic foam and pharmaceutical dosage form employing the same

#1549
20100099638
2010-04-22

Immunocompetent xenograft model

#1550
20100099632
2010-04-22

Oligosaccharide Aldonic Acids and Their Topical Use

#1551
20100093829
2010-04-15

METHODS FOR PREVENTING, POSTPONING OR IMPROVING THE OUTCOME OF SPINAL DEVICE AND FUSION PROCEDURES

#1552
20100080829
2010-04-01

LYOPHILIZED PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING AND USING SAME

#1553
20100076043
2010-03-25

Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use

#1554
20100076030
2010-03-25

Methods of treating rheumatoid arthritis

#1555
20100063109
2010-03-11

Thiadiazolidinone derivatives

#1556
20100055201
2010-03-04

Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles

#1557
20100048713
2010-02-25

COMPOUNDS ACTING ON THE SEROTONIN TRANSPORTER

#1558
20100048672
2010-02-25

Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications

#1559
20100048659
2010-02-25

Aqueous compositions containing metronidazole

#1560
20100048653
2010-02-25

NEUROPROTECTIVE MODULATION OF NMDA RECEPTOR SUBTYPE ACTIVITIES

#1561
20100048645
2010-02-25

Solubilizing of metronidazole

#1562
20100048595
2010-02-25

USE OF ARCHAEA TO MODULATE THE NUTRIENT HARVESTING FUNCTIONS OF THE GASTROINTESTINAL MICROBIOTA

#1563
20100047235
2010-02-25

NOVEL REGIMENS FOR TREATING DISEASES AND DISORDERS

#1564
20100041712
2010-02-18

SUBSTITUTED IMIDAZOLE COMBINATIONS

#1565
20100040609
2010-02-18

METHODS FOR PREVENTING, POSTPONING OR IMPROVING THE OUTCOME OF INVASIVE SPINAL PROCEDURES

#1566
20100035930
2010-02-11

Urea and sulfamide derivatives as inhibitors of TAFIa

#1567
20100029712
2010-02-04

Irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis

#1568
20100028417
2010-02-04

USE OF SUBSTITUTED GLYCERIN DERIVATIVES FOR PRODUCING A PHARMACEUTICAL PREPARATION

#1569
20100021402
2010-01-28

Compounds, formulations, and methods for ameliorating telangiectasis

#1570
20100016355
2010-01-21

ALPHA-2B ADRENERGIC RECEPTOR AGONIST AND SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR COMPOSITIONS FOR TREATING CHRONIC PAIN

#1571
20100016259
2010-01-21

Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators

#1572
20100004304
2010-01-07

METHODS AND COMPOSITIONS FOR THE TREATMENT OF MALIGNANT MELANOMA, BREAST, PROSTATE, COLON, PAPILLARY THYROID AND PANCREATIC CANCER

#1573
20100003353
2010-01-07

Control of blood vessel physiology to treat skin disorders

#1574
20090326607
2009-12-31

Electrical stimulation method for treatment of peripheral neuropathy

#1575
20090326063
2009-12-31

Synthetic triterpenoids and methods of use in the treatment of disease

#1576
20090326030
2009-12-31

Use of levo-ornidazole in the preparation of anti-anaerobic bacteria infection drugs

#1577
20090325994
2009-12-31

Methods of treating diarrhea caused by small intestinal bacterial overgrowth

#1578
20090318429
2009-12-24

Compounds, Compositions and Methods Comprising Heteroaromatic Derivatives

#1579
20090318378
2009-12-24

Antibiotic combinations for providing total solution to the treatment of infections

#1580
20090306149
2009-12-10

USE OF BIARYLCARBOXAMIES IN THE TREATMENT OF HEDGEHOG PATHWAY-RELATED DISORDERS

#1581
20090306125
2009-12-10

Mitochondria-Targeted Antioxidant Prodrugs and Methods of Use

#1582
20090286799
2009-11-19

METHODS FOR THE TREATMENT OF BRAIN EDEMA

#1583
20090285865
2009-11-19

Palatable, solid oral formulations for male chemical sterilization

#1584
20090270490
2009-10-29

METHODS INVOLVING ALDOSE REDUCTASE INHIBITION

#1585
20090253795
2009-10-08

Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation

#1586
20090253712
2009-10-08

AQUEOUS SOLVENT SYSTEM FOR SOLUBILIZATION OF AZOLE COMPOUNDS

#1587
20090253656
2009-10-08

BCRP/ABCG2 inhibitor

#1588
20090252802
2009-10-08

Compositions Including Relatively Water Insoluble/Unwettable Drugs And Methods For Using Same

#1589
20090252708
2009-10-08

Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof

#1590
20090246256
2009-10-01

Compositions and Methods for Transmucosal Delivery of Lofexidine

#1591
20090246174
2009-10-01

TREATMENT FOR CUTANEOUS T CELL LYMPHOMA

#1592
20090239922
2009-09-24

Kinesin inhibitors as cancer therapeutics

#1593
20090239918
2009-09-24

SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF

#1594
20090233970
2009-09-17

COMBINED NSAID AND ACID BLOCKER FORMULATION AND METHOD

#1595
20090227647
2009-09-10

Compounds, Compositions and Methods for the Treatment of Islet Amyloid Polypeptide (IAPP) Accumulation in Diabetes

#1596
20090226540
2009-09-10

Methods and compositions for treating feline hyperthyroidism

#1597
20090221706
2009-09-03

Methods of treating cognitive dysfunction by modulating brain energy metabolism

#1598
20090221656
2009-09-03

Drug Combinations

#1599
20090221591
2009-09-03

Selective inhibitors of human corticosteroid synthases

#1600
20090215849
2009-08-27

High stability aqueous gels comprising metronidazole and methods for the preparation thereof

#1601
20090209604
2009-08-20

Topical combination therapy for treating acne

#1602
20090208558
2009-08-20

Use of combination preparations comprising antifungal agents

#1603
20090202518
2009-08-13

Treatment of sepsis and inflammation with alphaadrenergic antagonists

#1604
20090198145
2009-08-06

COMPOSITIONS, METHODS, AND SYSTEMS FOR RAPID INDUCTION AND MAINTENANCE OF CONTINUOUS REM SLEEP

#1605
20090197959
2009-08-06

-disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors

#1606
20090197904
2009-08-06

Sulphamides for treatment of cancer

#1607
20090197896
2009-08-06

Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water

#1608
20090191262
2009-07-30

Use of compounds of formula A-R-Xo pharmaceutically acceptable salts thereof for producing a pharmaceutically preparations

#1609
20090186929
2009-07-23

Method and agent for inducing apoptosis/cell death in leukemia cells

#1610
20090181106
2009-07-16

Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms

#1611
20090176737
2009-07-09

Composition for soft contact lens and adsorption suppressing method

#1612
20090169591
2009-07-02

MEDICAL ARTICLES FOR THE TREATMENT OF TUMORS

#1613
20090163568
2009-06-25

AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA

#1614
20090163549
2009-06-25

Pharmaceutical Composition Comprising an Amide Derivative

#1615
20090163500
2009-06-25

Compositions and methods for treating lysosomal disorders

#1616
20090156562
2009-06-18

NOVEL COLORED SOLUTIONS OF INJECTABLE DRUGS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS

#1617
20090155326
2009-06-18

Layered drug delivery polymer monofilament fibers

#1618
20090149523
2009-06-11

USE OF N-AMINOIMIDAZOLE CYTOPROTECTIVE COMPOUNDS FOR TREATING CELL DEATH AND/OR GSK-3 MEDIATED DISEASES

#1619
20090148538
2009-06-11

USE OF ADSORBENT CARBON MICROSPHERES TO TREAT POUCHITIS

#1620
20090143279
2009-06-04

Methods and compositions for treating metabolic disorders

#1621
20090142735
2009-06-04

Bacterial intraoral disease treatment composition, washing treatment solution, hemostatic treatment solution, and bacterial intraoral disease treatment method

#1622
20090142278
2009-06-04

Effervescent compositions comprising phosphonates and methods related thereto

#1623
20090137556
2009-05-28

COSMETIC AND PHARMACEUTICAL COMPOSITIONS COMPRISING ACE INHIBITORS AND/OR ANGIOTENSIN II RECEPTOR ANTAGONISTS

#1624
20090124674
2009-05-14

Method for treating congestive heart failure

#1625
20090124673
2009-05-14

Method for treating diabetic nephropathy

#1626
20090123429
2009-05-14

-based compositions and uses thereof

#1627
20090118334
2009-05-07

METHOD OF TREATMENT OF CARDIAC AND/OR RENAL FAILURE USING A CALCIUM CHANNEL BLOCKER AND AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR OR AN ANGIOTENSIN II RECEPTOR BLOCKER

#1628
20090118301
2009-05-07

Compositions and Methods for Treating Cancer

#1629
20090118237
2009-05-07

Carisoprodol, Phenytoin and Fosphenytoin Articles and Methods

#1630
20090111863
2009-04-30

Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies

#1631
20090105278
2009-04-23

Selective inhibitors of human corticosteroid syntheses

#1632
20090082457
2009-03-26

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

#1633
20090082411
2009-03-26

Pharmaceutical for prevention or treatment of bone metabolic disease

#1634
20090081161
2009-03-26

Infection and treatment of neoplasms with vesicular stomatitis virus

#1635
20090075932
2009-03-19

Method of selectively inhibiting PKCiota

#1636
20090075864
2009-03-19

Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators

#1637
20090062235
2009-03-05

Inhibitors of Dipeptidylpeptidase IV

#1638
20090054491
2009-02-26

Use

#1639
20090054403
2009-02-26

Treatment of Post-Traumatic Stress Disorder

#1640
20090053308
2009-02-26

Release-control composition

#1641
20090042965
2009-02-12

Inhibitors for steroid response elements and related methods

#1642
20090041800
2009-02-12

Methods for Treating Dependence

#1643
20090041667
2009-02-12

Treatment of Depressive Disorders

#1644
20090035302
2009-02-05

Rage Antagonists As Agents To Reverse Amyloidosis And Diseases Associated Therewith

#1645
20090030060
2009-01-29

INTRAVAGINAL TREATMENT OF VAGINAL INFECTIONS WITH METRONIDAZOLE COMPOSITIONS

#1646
20090029970
2009-01-29

PAIN REMEDY CONTAINING ROCK INHIBITOR

#1647
20090023691
2009-01-22

DELAYING THE AGEING PROCESS AND DISORDERS CAUSED BY AGEING

#1648
20090023228
2009-01-22

Dual-acting imidazole antihypertensive agents

#1649
20090018087
2009-01-15

Inhibitors of glutaminyl cyclase

#1650
20090012113
2009-01-08

Methods of treating a subject suffering from irritable bowel syndrome

#1651
20090005410
2009-01-01

N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides

#1652
20080319041
2008-12-25

Lofexidine enantiomers for use as a treatment for CNS disease and pathologies and its chiral synthesis

#1653
20080317737
2008-12-25

Drug combination for the treatment of skin disorders

#1654
20080312304
2008-12-18

Topical compositions containing metronidazole

#1655
20080312245
2008-12-18

Methods and compositions for treating acne and other infectious diseases

#1656
20080311074
2008-12-18

Inhibitors against activation of NF-kappaB

#1657
20080300265
2008-12-04

Antiviral drugs for treatment of arenavirus infection

#1658
20080287515
2008-11-20

Topical compositions containing metronidazole

#1659
20080287514
2008-11-20

Topical compositions containing metronidazole

#1660
20080287513
2008-11-20

Topical compositions containing metronidazole

#1661
20080287429
2008-11-20

Dissolution of Arterial Cholesterol Plaques by Pharmacologically Induced Elevation of Endogenous Bile Salts

#1662
20080275016
2008-11-06

FULVENE AND FULVALENE ANALOGS AND THEIR USE IN TREATING CANCERS

#1663
20080269344
2008-10-30

Beta2-Adrenergic Receptor Agonists

#1664
20080269305
2008-10-30

Dual-acting antihypertensive agents

#1665
20080269217
2008-10-30

Melanocortin-4 receptor binding compounds and methods of use thereof

#1666
20080269215
2008-10-30

Bisamide inhibitors of hedgehog signaling

#1667
20080268066
2008-10-30

Synergistic Formulation for Preventing and/or Treating Diabetes

#1668
20080254010
2008-10-16

Controlling Clostridium difficile-Associated Disease in the Gastrointestinal Tract

#1669
20080248032
2008-10-09

COMPOSITIONS AND METHODS FOR PROTECTION AGAINST CARDIAC AND/OR CENTRAL NERVOUS SYSTEM TISSUE INJURY BY INHIBITING SPHINGOSINE-1-PHOSPHATE LYASE

#1670
20080234341
2008-09-25

Carisoprodol and Phenytoin Methods

#1671
20080234233
2008-09-25

MEDICAMENT FOR TREATMENT OF NEURODEGENERATIVE DISEASES

#1672
20080234204
2008-09-25

Methods for evaluating and implementing prostate disease treatments

#1673
20080233195
2008-09-25

Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth

#1674
20080233193
2008-09-25

ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS

#1675
20080221189
2008-09-11

Use of Metronidazole For Preparing a Pharmaceutical Composition For Treating Pathologies Related to the B-Type Receptor of Interleukin 8 and/or to a Pacap Type 1 Receptor

#1676
20080220092
2008-09-11

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

#1677
20080214448
2008-09-04

Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide

#1678
20080213398
2008-09-04

Modified azole compounds as antifungal and antibacterial agents

#1679
20080213378
2008-09-04

Nanoparticulate statin formulations and novel statin combinations

#1680
20080207719
2008-08-28

Treatment of Epilepsy

#1681
20080200693
2008-08-21

Derivatives of Aryl (or Heteroaryl) Azolylcarbinols (in Particular Cizolirtin Citrate) for the Treatment of Opioid Addiction

#1682
20080194667
2008-08-14

Compositions for treating amyloid associated diseases

#1683
20080194664
2008-08-14

Avermectin/metronidazole compositions for treating afflictions of the skin, e.g., rosacea

#1684
20080194662
2008-08-14

CLEANSER COMPOSITION

#1685
20080193499
2008-08-14

Angiogenesis inhibitors

#1686
20080187605
2008-08-07

PREVENTING PATHOLOGICAL NERVE CELL SUICIDE (NEUROAPOPTOSIS) IN IMMATURE NERVOUS SYSTEMS

#1687
20080182885
2008-07-31

Modified Azole Compounds As Antifungal and Antibacterial Agents

#1688
20080182811
2008-07-31

METABOTROPIC GLUTAMATE RECEPTOR ACTIVATOR

#1689
20080177083
2008-07-24

Use of Levo-Ornidazole For Preparing Anti-Parasitic Infection Drug

#1690
20080176918
2008-07-24

Nonsedating Alpha-2 Agonists

#1691
20080175831
2008-07-24

NEUROPROTECTION BY BLOOD FLOW STABILIZATION

#1692
20080167388
2008-07-10

Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis

#1693
20080161375
2008-07-03

Solubilizing of metronidazole

#1694
20080161246
2008-07-03

Cytochrome P450 Oxidase Inhibitors and Uses Thereof

#1695
20080154030
2008-06-26

Method for increasing the solubility of betacyclodextrin

#1696
20080153881
2008-06-26

ALPHA-2B RECEPTOR AGONIST AND ACID REDUCER COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS

#1697
20080153880
2008-06-26

PAN-ALPHA-2 RECEPTOR AGONIST AND ACID REDUCER COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS

#1698
20080153876
2008-06-26

Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor

#1699
20080153874
2008-06-26

ALPHA-2B RECEPTOR AGONIST AND ANTICONVULSANT COMPOSITIONS FOR TREATING CHRONIC PAIN

#1700
20080153832
2008-06-26

PAN-ALPHA-2 RECEPTOR AGONIST AND RELAXANT COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS

#1701
20080153829
2008-06-26

PAN-ALPHA-2 RECEPTOR AGONIST AND 5HT4 SEROTONIN RECEPTOR COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS

#1702
20080153122
2008-06-26

Method and system for enhancing self-treatment of onychomycosis

#1703
20080146635
2008-06-19

2-((2-thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one

#1704
20080145434
2008-06-19

Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use

#1705
20080139664
2008-06-12

ANTI-GLYCATION AGENTS FOR PREVENTING AGE-, DIABETES-, AND SMOKING-RELATED COMPLICATIONS

#1706
20080139635
2008-06-12

Inflammation therapy

#1707
20080138383
2008-06-12

COMPOSITIONS AND METHODS FOR TREATING SEIZURES

#1708
20080138293
2008-06-12

Cosmetic and pharmaceutical foam

#1709
20080114032
2008-05-15

Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor

#1710
20080114025
2008-05-15

Cardiovascular compositions and methods using combinations of anti-platelet agents

#1711
20080112945
2008-05-15

Synergistic compositions and methods for enhancing potency and/or for prolonging the duration of action of anesthetics

#1712
20080108681
2008-05-08

Use of allantoin as a pro-collagen synthesis agent in cosmetic compositions

#1713
20080108658
2008-05-08

METHODS OF PROMOTING OSTEOGENESIS

#1714
20080107727
2008-05-08

Multiple Unit Oral Sustained Release Preparation and Production Method Thereof

#1715
20080103117
2008-05-01

Treatment Product for Animals and Means for Preparing Same

#1716
20080096948
2008-04-24

Serotonin antagonist compositions and methods for the local inhibition of pain and inflammation

#1717
20080096888
2008-04-24

Compounds as opioid receptor modulators

#1718
20080090891
2008-04-17

ION CHANNEL MODULATORS

#1719
20080090825
2008-04-17

Metallo-β-lactamase inhibitors

#1720
20080090772
2008-04-17

Oligosaccharide Aldonic Acids and Their Topical Use

#1721
20080081078
2008-04-03

Prevention of Cell Proliferation by Inhibiting Myosin Light Chain Kinase

#1722
20080070948
2008-03-20

BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS

#1723
20080070869
2008-03-20

Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators

#1724
20080058400
2008-03-06

Skin external preparation

#1725
20080058340
2008-03-06

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

#1726
20080045575
2008-02-21

Delivery of H2 Antagonists

#1727
20080044439
2008-02-21

Compositions and Methods for Preventing and Treating Skin and Hair Conditions

#1728
20080039461
2008-02-14

Treatment of pain by inhibition of p38 map kinase

#1729
20080038203
2008-02-14

Compositions and methods for topical diagnostic and therapeutic transport

#1730
20080032994
2008-02-07

Modified azole compounds as antifungal and antibacterial agents

#1731
20080032937
2008-02-07

Bioavailability and Improved Delivery of Alkaline Pharmaceutical Drugs

#1732
20080031941
2008-02-07

Gastric acid secretion inhibiting composition

#1733
20080031907
2008-02-07

COSMETIC AND PHARMACEUTICAL FOAM

#1734
20080027052
2008-01-31

METHODS FOR TREATING CYSTIC KIDNEY DISEASE

#1735
20080027025
2008-01-31

Protection From And Treatment Of Prion Protein Infection

#1736
20080019975
2008-01-24

Novel Regimens for Treating Diseases and Disorders

#1737
20080019970
2008-01-24

METHODS FOR PREVENTING, POSTPONING OR IMPROVING THE OUTCOME OF SPINAL DEVICE AND FUSION PROCEDURES

#1738
20080019969
2008-01-24

Methods for Preventing, Postponing or Improving the Outcome of Invasive Spinal Procedures

#1739
20080014185
2008-01-17

Methods of treating diarrhea and bloating caused by small intestinal bacterial overgrowth

#1740
20080014184
2008-01-17

Methods of treating fibromyalgia caused by small intestinal bacterial overgrowth

#1741
20080009520
2008-01-10

BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS

#1742
20080008694
2008-01-10

METHODS TO PREVENT AND TREAT DISEASES

#1743
20080004310
2008-01-03

LYOPHILIZED PHARMACEUTICAL COMPOSITION

#1744
20080004266
2008-01-03

Method for treating proliferative disorders with HSP90 inhibitors

#1745
20080003181
2008-01-03

Treatment of depressive disorders

#1746
20070293555
2007-12-20

Azole derivatives and pharmaceutical compositions containing them

#1747
20070292355
2007-12-20

Anti-infection augmentation foamable compositions and kit and uses thereof

#1748
20070281984
2007-12-06

Use Of Metronidazole For Preparing A Pharmaceutical Composition For Treating A Cutaneous Inflammation

#1749
20070276021
2007-11-29

Method for treatment of neurodegenerative disorders

#1750
20070270409
2007-11-22

Medicament for Preventing and/or Treating Ischemic Cardiovascular Disease

#1751
20070265324
2007-11-15

Combination Therapy with Parp Inhibitors

#1752
20070265240
2007-11-15

Sequence selective pyrrole and imidazole polyamide metallocomplexes

#1753
20070259889
2007-11-08

Protein Binding Compounds

#1754
20070259841
2007-11-08

Combinations for the treatment of rheumatoid arthritis

#1755
20070254934
2007-11-01

Antiviral drugs for treatment of arenavirus infection

#1756
20070248664
2007-10-25

Oral antimicrobial pharmaceutical compositions

#1757
20070238772
2007-10-11

Use of Metronidazole for Preparing a Pharmaceutical Composition for Treating a Cutaneous Vascularisation Disorder

#1758
20070238732
2007-10-11

BRIMONIDINE AND TIMOLOL COMPOSITIONS

#1759
20070232664
2007-10-04

Iron binding agents

#1760
20070231358
2007-10-04

INTRAVAGINAL TREATMENT OF VAGINAL INFECTIONS WITH METRONIDAZOLE COMPOSITIONS

#1761
20070224226
2007-09-27

COMPOSITION AND METHOD OF USE THEREOF

#1762
20070219263
2007-09-20

Metronidazole/azelaic acid compositions for the treatment of rosacea

#1763
20070219239
2007-09-20

Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents

#1764
20070213369
2007-09-13

NOVEL NON-PSYCHOTROPIC CANNABINOIDS

#1765
20070213362
2007-09-13

2-NH-HETEROARYLIMIDAZOLES WITH ANTIBACTERIAL ACTIVITY

#1766
20070208067
2007-09-06

Tablet Formulations and Processes

#1767
20070208063
2007-09-06

Imidazole-based compounds, compositions comprising them and methods of their use

#1768
20070208058
2007-09-06

Stable Pharmaceutical Compositions and Methods of Making and Using Same

#1769
20070208048
2007-09-06

Aryl imidazoles and related compounds as C5a receptor modulators

#1770
20070203144
2007-08-30

Use of Memantine and Brimonidine to Attenuate Vitreoretinal Vascular Endothelial Growth Factor (VEGF) Protein Levels in Animals

#1771
20070203104
2007-08-30

Pharmaceutical Formulations

#1772
20070197621
2007-08-23

Method for the treatment of CNS disorders with substituted 2-imidazoles or imidazole derivatives

#1773
20070197569
2007-08-23

Method for treating central nervous system disorders with substituted 2-imidazoline derivatives

#1774
20070197562
2007-08-23

Remedies for prostatic hypertrophy

#1775
20070191448
2007-08-16

Ion channel modulators

#1776
20070191371
2007-08-16

HETEROCYCLIC MODULATORS OF PPAR

#1777
20070185181
2007-08-09

Treatment or prevention of hypotension and shock

#1778
20070179179
2007-08-02

β2-adrenergic receptor agonists

#1779
20070173462
2007-07-26

Treatment of diseases associated with the use of antibiotics

#1780
20070161711
2007-07-12

Process for producing pellets for pharmaceutical compositions

#1781
20070142291
2007-06-21

Methods for treating irritable bowel syndrome

#1782
20070135505
2007-06-14

Aralkyl ester soft drugs

#1783
20070105929
2007-05-10

2,4,5-trisubstituted imidazoles and their use as anti-microbial agents

#1784
20070105788
2007-05-10

Azithromycin for treatment of granulomatous rosacea

#1785
20070099975
2007-05-03

Imidazole derivatives modulating the sodium channels

#1786
20070099892
2007-05-03

Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging

#1787
20070088024
2007-04-19

Active substance combination comprising a carbinol combined to at least an NSAID

#1788
20070087998
2007-04-19

Imidazole compounds that modulate HSP90 activity

#1789
20070082893
2007-04-12

Active substance combination

#1790
20070078116
2007-04-05

Method of treatment of otitis externa

#1791
20070072917
2007-03-29

Substituted 2-aminotetralin for the treatment of depression

#1792
20070066586
2007-03-22

Aniline derivatives

#1793
20070060632
2007-03-15

Lofexidine

#1794
20070060501
2007-03-15

Methods and therapies for potentiating a therapeutic action of an opioid receptor agonist and inhibiting and/or reversing tolerance to opioid receptor agonists

#1795
20070053849
2007-03-08

Oral care compositions containing combinations of anti-bacterial and host-response modulating agents

#1796
20070049631
2007-03-01

Ectoparasiticidal formulations of spinosyms and azole pesticides

#1797
20070043016
2007-02-22

Method of treating fibrotic diseases or other indications with imidazolium agents

#1798
20070042951
2007-02-22

Pharmaceutical compositions comprising alpha-2-adrenergics and trefoil factor family peptides

#1799
20070031497
2007-02-08

Gastric acid secretion inhibiting composition

#1800
20070027090
2007-02-01

Methods of treating cognitive dysfunction by modulating brain energy metabolism